Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

3articles mentioning treatments

6treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: BQT ×

BQT

This treatment is selected. Its supporting articles are shown below.

BQT3

Articles mentioning BQT

3 articles · page 1 of 1

IDDF2026-ABS-0527 Efficacy and influencing factors of different eradication regimens for treatment-naive helicobacter pylori in clinical practice

gutjnl · abstract · 2026-06-26 · 4 matching annotations

86.1%

BQT DT H. pylori minocycline Helicobacter pylori doxycycline clarithromycin

…Naive Helicobacter pylori).Conclusions These findings show that BQT generally outperforms DT for treatment-naive H. pylori infectio…

IDDF2026-ABS-0349 High-level clarithromycin resistance creates an iron-dependent metabolic vulnerability targetable by bismuth: a real-world study in chinese pediatric helicobacter pylori infection

gutjnl · abstract · 2026-06-26 · 1 matching annotations

80.1%

BQT Clarithromycin Bismuth H. pylori Helicobacter pylori Bismuth-CLA CLA IDDF2026-ABS-0349

… assays, and iron chelation/supplementation experiments.Results BQT achieved superior eradication for CLA-resistant infections (93.…

IDDF2026-ABS-0350 Closing the additive window: suboptimal metronidazole dosing abolishes bismuth benefit in paediatric helicobacter pylori infection—a real-world study in china

gutjnl · abstract · 2026-06-26 · 1 matching annotations

75.7%

BQT H. pylori Helicobacter pylori metronidazole National Children’s Medical Centre bismuth clarithromycin

…was double CLA resistance (25.3%). In MET-resistant infections, BQT offered no benefit over triple therapy (TT) (80.0% vs 73.8%, p=…